Reents Scott T (CIK 1937048) reported 11 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2026-03-03). Recent activity: Sell ABBV (21,638 shares), Buy ABBV (25,062 shares), Buy ABBV (8,910 shares), Buy ABBV (7,606 shares), Buy ABBV (7,260 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-03-03 | AbbVie Inc. (ABBV) | EVP, CHIEF FINANCIAL OFFICER | Sell | 21,638 | $5.0M |
| 2026-02-20 | AbbVie Inc. (ABBV) | EVP, CHIEF FINANCIAL OFFICER | Buy | 25,062 | $0 |
| 2026-02-20 | AbbVie Inc. (ABBV) | EVP, CHIEF FINANCIAL OFFICER | Buy | 8,910 | $0 |
| 2026-02-20 | AbbVie Inc. (ABBV) | EVP, CHIEF FINANCIAL OFFICER | Buy | 7,606 | $0 |
| 2026-02-20 | AbbVie Inc. (ABBV) | EVP, CHIEF FINANCIAL OFFICER | Buy | 7,260 | $0 |
| 2025-03-18 | AbbVie Inc. (ABBV) | EVP, CHIEF FINANCIAL OFFICER | Sell | 17,644 | $3.7M |
| 2025-03-04 | AbbVie Inc. (ABBV) | EVP, CHIEF FINANCIAL OFFICER | Sell | 10,973 | $2.2M |
| 2025-02-18 | AbbVie Inc. (ABBV) | EVP, CHIEF FINANCIAL OFFICER | Buy | 5,845 | $0 |
| 2025-02-18 | AbbVie Inc. (ABBV) | EVP, CHIEF FINANCIAL OFFICER | Buy | 2,398 | $0 |
| 2025-02-18 | AbbVie Inc. (ABBV) | EVP, CHIEF FINANCIAL OFFICER | Buy | 8,912 | $0 |
| 2025-02-18 | AbbVie Inc. (ABBV) | EVP, CHIEF FINANCIAL OFFICER | Buy | 7,608 | $0 |
Source: SEC Form 4 filings · as of 2026-03-03